Explore more publications!
Mississippi Healthcare Reporter
Got News to Share?

Mississippi Healthcare Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Mississippi Healthcare Reporter.

February 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

Press releases published on April 28, 2026

uniQure to Announce First Quarter 2026 Financial Results
24 minutes ago

uniQure to Announce First Quarter 2026 Financial Results

Indeterminate GlobeNewswire
Kraig Biocraft Laboratories Reports Major Progress Converting Record-Setting Spider Silk Cocoon Production into Reeled Silk
24 minutes ago

Kraig Biocraft Laboratories Reports Major Progress Converting Record-Setting Spider Silk Cocoon Production into Reeled Silk

Indeterminate GlobeNewswire
Coultreon Biopharma Raises $125 Million in Series A Financing to Advance Immunology Pipeline
29 minutes ago

Coultreon Biopharma Raises $125 Million in Series A Financing to Advance Immunology Pipeline

Indeterminate GlobeNewswire
Coave Therapeutics to unveil OneAAVTM universal capsid at ASGCT 2026, paving the way for third generation gene therapy vectors
29 minutes ago

Coave Therapeutics to unveil OneAAVTM universal capsid at ASGCT 2026, paving the way for third generation gene therapy vectors

Indeterminate GlobeNewswire
BioCryst to Present at Upcoming Investor Conferences
29 minutes ago

BioCryst to Present at Upcoming Investor Conferences

Indeterminate GlobeNewswire
Avalo Therapeutics Purchases Optional Milestone Buyout
29 minutes ago

Avalo Therapeutics Purchases Optional Milestone Buyout

Indeterminate GlobeNewswire
Ocular Therapeutix™ to Report First Quarter 2026 Financial Results on May 5, 2026
29 minutes ago

Ocular Therapeutix™ to Report First Quarter 2026 Financial Results on May 5, 2026

Indeterminate GlobeNewswire
Benitec Biopharma Announces Oral Presentation of Interim Phase 1b/2a Clinical Study Results for High Dose BB-301 and Continued Durable Improvements for Low Dose BB-301 at the 2026 American Society of Gene and Cell Therapy Annual Meeting
29 minutes ago

Benitec Biopharma Announces Oral Presentation of Interim Phase 1b/2a Clinical Study Results for High Dose BB-301 and Continued Durable Improvements for Low Dose BB-301 at the 2026 American Society of Gene and Cell Therapy Annual Meeting

Indeterminate GlobeNewswire
Axogen, Inc. Reports First Quarter 2026 Financial Results
29 minutes ago

Axogen, Inc. Reports First Quarter 2026 Financial Results

Indeterminate GlobeNewswire
Manitoba Harvest Launches Superfood Smoothie Boosters, Exclusively at Sprouts Farmers Market Nationwide
29 minutes ago

Manitoba Harvest Launches Superfood Smoothie Boosters, Exclusively at Sprouts Farmers Market Nationwide

Indeterminate GlobeNewswire
EvolveImmune Therapeutics Announces Achievement of Preclinical Milestone in Collaboration with AbbVie
29 minutes ago

EvolveImmune Therapeutics Announces Achievement of Preclinical Milestone in Collaboration with AbbVie

Indeterminate GlobeNewswire
mbiomics Announces Third Closing of Series A, Reaching €30 Million to Advance Microbiome Therapeutics
29 minutes ago

mbiomics Announces Third Closing of Series A, Reaching €30 Million to Advance Microbiome Therapeutics

Indeterminate GlobeNewswire
Climb Bio, Inc. Announces $110.0 Million Private Placement
29 minutes ago

Climb Bio, Inc. Announces $110.0 Million Private Placement

Indeterminate GlobeNewswire
Burning Rock Publishes 2025 Annual Report on Form 20-F
44 minutes ago

Burning Rock Publishes 2025 Annual Report on Form 20-F

Indeterminate GlobeNewswire
Aclaris Therapeutics Announces Positive Full Top Line First-in-Human Results from Phase 1a Healthy Volunteer Clinical Trial of ATI-052, a Novel Potential First-in-Class Anti-TSLP/IL-4Rα Bispecific Antibody, and Announces Lichen Planus as Lead…
an hour ago

Aclaris Therapeutics Announces Positive Full Top Line First-in-Human Results from Phase 1a Healthy Volunteer Clinical Trial of ATI-052, a Novel Potential First-in-Class Anti-TSLP/IL-4Rα Bispecific Antibody, and Announces Lichen Planus as Lead…

Indeterminate GlobeNewswire
RadNet, Inc. Announces Date of its First Quarter 2026 Financial Results Conference Call
1 hours ago

RadNet, Inc. Announces Date of its First Quarter 2026 Financial Results Conference Call

Indeterminate GlobeNewswire
The Ensign Group Schedules First Quarter 2026 Earnings Call for Friday, May 1, 2026
1 hours ago

The Ensign Group Schedules First Quarter 2026 Earnings Call for Friday, May 1, 2026

Indeterminate GlobeNewswire
Aclarion Appoints Daniel Keefe as Commercial Director, Western U.S., to Drive Continued Adoption of Nociscan
1 hours ago

Aclarion Appoints Daniel Keefe as Commercial Director, Western U.S., to Drive Continued Adoption of Nociscan

Indeterminate GlobeNewswire
Anteris Technologies Secures CMS Reimbursement Supporting U.S. Site Activation for PARADIGM Trial
1 hours ago

Anteris Technologies Secures CMS Reimbursement Supporting U.S. Site Activation for PARADIGM Trial

Indeterminate GlobeNewswire
KFSH Awards Innovation Challenge Winners at C3 Davos of Healthcare™ Silicon Valley Summit
2 hours ago

KFSH Awards Innovation Challenge Winners at C3 Davos of Healthcare™ Silicon Valley Summit

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions